Status:
RECRUITING
Nutrition Impact on PRGF Treatment for Tendinopathy
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Shoulder Tendinopathy
Metabolic Alterations
Eligibility:
All Genders
18-70 years
Brief Summary
Given the close correlation reported in the literature between onset and progression of tendon pathology in subjects affected by the alteration of metabolic disorders such as obesity, diabetes mellitu...
Detailed Description
This is a single-center, observational study with an additional procedure (extra blood sampling routine, food questionnaires, anthropometric measurements for the evaluation of nutritional status), pro...
Eligibility Criteria
Inclusion
- Male and female
- Age ≥18 years and ≤ 70 years
- Patients presenting shoulder tendinopathy
- Signing of the Informed Consent of the Regain observational study
- Signature of informed consent of the present study.
Exclusion
- Pregnancy (ascertained by self-declaration), breastfeeding
- Inability to follow the study protocol
- Heart, kidney, oncological disease
- Neuropsychiatric disease
- Other conditions that, at the discretion of the investigator or physician, exclude enrollement
Key Trial Info
Start Date :
February 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 15 2027
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06536582
Start Date
February 15 2024
End Date
February 15 2027
Last Update
August 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Milan, Italy, 20173